Mycoplasma: A new potential vector for gene therapy?

Medical Hypotheses

Volumn 52, Issue 6, 1999, Pages 605-607

  Berger, F ^a   Canova, C ^b   Vicat, J M ^a   Benabid, A L ^a   Wion, D ^a  

^a HÔPITAL MICHALLON   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN;

ANTIBIOTIC SENSITIVITY; BACTERIUM TRANSDUCTION; CELL ADHESION; CELL SURFACE; EXPRESSION VECTOR; GENE EXPRESSION; GENE THERAPY; MYCOPLASMA; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SHORT SURVEY; TARGET CELL;

EID: 0032999392     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.1998.0816     Document Type: Article

References (14)

1. Avery O. T., Macleod C. M., McCarty M. Studies on the chemical nature of the substance inducing transformation of Pneumococcal types. J Exp Med. 79:1944;137-158.
2. Kaiser A. D., Hogness D. S. J. The transformation of Escherichia coli with deoxyribonucleic acid isolated from bacteriophage λδ Mol Biol. 2:1960;392-415.
3. Zinder N., Lederberg J. J. Genetic exchange in Salmonella. Bacteriology. 64:1952;679-699.
4. Lederberg J., Tatum E. L. Gene recombination in Escherichia coli. Nature. 158:1946;558.
5. Culver K. W. Clinical applications of gene therapy for cancer. Clin Chem. 40:1994;510-512.
6. Connors T. A. The choice of prodrugs for gene directed enzyme prodrug therapy of cancer. Gene Ther. 2:1995;702-709.
7. Mullen C. A., Kilstrup M., Blaese R. M. Transfer of the bacterial gene for cytosine deaminase to mammalian cells confer lethal sensitivity to 5-fluorocytosine: a negative selection system. Proc Natl Acad Sci USA. 98:1992;33-37.
8. Sorscher E. J., Peng S., Bebok Z., Allan P. W., Bennett L. L., Parker W. B. Tumor cell bystander killing in colonic carcinoma utilizing the Escherichia coli DeoD gene to generate toxic purines. Gene Ther. 1:1994;233-238.
9. Culver K. W., Ram Z., Wallbridge S., Ishii H., Oldfield E. H., Blaese R. M. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science. 256:1992;1550-1552.
10. Ram Z., Culver K. W., Oshiro E. M. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nature Med. 3:1997;1354-1361.
11. Razin S. Peculiar properties of mycoplasmas: the smallest self-replicating prokaryotes. Microbiol Lett. 100:1992;423-432.
12. McGarrity G. J., Carson D. A. Adenosine phosphorylase-mediated nucleoside toxicity. Exp Cell Res. 139:1982;199-205.
13. Boris-Lawrie K., Temin H. M. The retroviral vector. Replication cycle and safety considerations for retrovirus-mediated gene therapy. Ann NY Acad Sci. 716:1994;59-70.
14. Labat-Moleur F., Steffan A.-M., Brisson C. An electron microscopy study into the mechanism of gene transfer with lipopolyamines. Gene Ther. 3:1996;1010-1017.